Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelialcells and astrocytes
Pj. Gaillard et al., Establishment and functional characterization of an in vitro model of the blood-brain barrier, comprising a co-culture of brain capillary endothelialcells and astrocytes, EUR J PH SC, 12(3), 2001, pp. 215-222
Objective: The aim was to establish a flexible, abundantly available, repro
ducible and functionally characterized in vitro model of the blood-brain ba
rrier (BBB). Methods: In a first step, bovine brain capillaries and newborn
rat astrocytes were isolated. Subsequently, a co-culture of primary brain
capillary endothelial cells (BCEC) on semi-permeable filter inserts, with a
strocytes on the bottom of the filter was established. The cell material wa
s characterized on the basis of specific cell-type properties and (function
al expression of) specific BBB properties. Results: BCEC displayed: (1) cha
racteristic endothelial cell morphology; (2) expression of endothelial cell
markers (i.e., CD51, CD62P, CD71 and cadherin 5); (3) marginal F-actin loc
alization; (4) tight junction formation between the cells; (5) expression o
f gamma -glutamyl-transpeptidase (gamma -GTP); (6) expression of P-glycopro
tein (Pgp); (7) functional transendothelial transferrin transport and uptak
e; (8) restriction of paracellular transport; and (9) high transendothelial
electrical resistance (TEER). Astrocytes displayed characteristic astrocyt
e morphology and expressed glial fibrillary acidic protein (GFAP). Co-cultu
re with astrocytes increased TEER and decreased paracellular transport. In
addition, expression of the glucocorticoid receptor (GR) was demonstrated i
n the endothelial cells of the BBB, while no expression of the mineralocort
icoid receptor (MR) was found. Conclusions: A high quality and mass-product
ion in vitro BBB model was established in which experiments with physiologi
cal (e.g., regulation of BBB permeability), pharmacological (e.g., pharmaco
kinetics and pharmacodynamics) and pathophysiological (e.g., disease influe
nce on BBB permeability) objectives can be reproducibly performed. (C) 2001
Elsevier Science B.V. All rights reserved.